Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19

0 avis

Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19

Archive ouverte

Edité par CCSD ; Springer Verlag -

International audience. Chlorpromazine has been suggested as being potentially useful in patients with coronavirus disease 2019 (COVID-19) on the grounds of its potential antiviral and anti-inflammatory effects.

Langue: en

Indexation

Consulter en ligne

Consulter le document

Suggestions

Du même auteur

A Comprehensive Analysis of Immune Constituents in Blood and Bronchoalveolar Lavage Allows Identification of an Immune Signature of Severe Asthma in Children

Archive ouverte | Adel-Patient, Karine | CCSD

International audience. Background; Targeted approaches may not account for the complexity of inflammation involved in children with severe asthma (SA), highlighting the need to consider more global analyses. We aim...

Immune signatures distinguish frequent from non-frequent exacerbators among children with severe asthma

Archive ouverte | Adel-Patient, Karine | CCSD

International audience

Evidence for a MAIT-17–high phenotype in children with severe asthma

Archive ouverte | Lezmi, Guillaume | CCSD

International audience

Chargement des enrichissements...